Charles Schwab’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1M | Buy |
716,798
+13,082
| +2% | +$275K | ﹤0.01% | 1815 |
|
|
2025
Q1 | $11.5M | Sell |
703,716
-9,095
| -1% | -$149K | ﹤0.01% | 1887 |
|
|
2024
Q4 | $18.3M | Buy |
712,811
+23,738
| +3% | +$610K | ﹤0.01% | 1744 |
|
|
2024
Q3 | $21.8M | Buy |
689,073
+78,518
| +13% | +$2.49M | ﹤0.01% | 1649 |
|
|
2024
Q2 | $21.4M | Buy |
610,555
+40,966
| +7% | +$1.44M | ﹤0.01% | 1636 |
|
|
2024
Q1 | $25M | Buy |
569,589
+73,133
| +15% | +$3.21M | 0.01% | 1484 |
|
|
2023
Q4 | $17.7M | Buy |
496,456
+59,100
| +14% | +$2.1M | ﹤0.01% | 1670 |
|
|
2023
Q3 | $11.8M | Buy |
437,356
+291,240
| +199% | +$7.86M | ﹤0.01% | 1827 |
|
|
2023
Q2 | $3.43M | Buy |
146,116
+26,913
| +23% | +$632K | ﹤0.01% | 2376 |
|
|
2023
Q1 | $1.64M | Buy |
119,203
+1,065
| +0.9% | +$14.6K | ﹤0.01% | 2576 |
|
|
2022
Q4 | $2.15M | Buy |
118,138
+26,434
| +29% | +$480K | ﹤0.01% | 2549 |
|
|
2022
Q3 | $1.37M | Buy |
91,704
+885
| +1% | +$13.2K | ﹤0.01% | 2701 |
|
|
2022
Q2 | $1.25M | Buy |
90,819
+5,247
| +6% | +$72.4K | ﹤0.01% | 2710 |
|
|
2022
Q1 | $958K | Buy |
85,572
+2,109
| +3% | +$23.6K | ﹤0.01% | 2862 |
|
|
2021
Q4 | $1.97M | Buy |
83,463
+278
| +0.3% | +$6.58K | ﹤0.01% | 2710 |
|
|
2021
Q3 | $2.12M | Buy |
83,185
+17,549
| +27% | +$447K | ﹤0.01% | 2692 |
|
|
2021
Q2 | $1.38M | Buy |
65,636
+21,814
| +50% | +$458K | ﹤0.01% | 2825 |
|
|
2021
Q1 | $1.03M | Buy |
43,822
+4,614
| +12% | +$108K | ﹤0.01% | 2847 |
|
|
2020
Q4 | $549K | Hold |
39,208
| – | – | ﹤0.01% | 2956 |
|
|
2020
Q3 | $493K | Buy |
39,208
+13,285
| +51% | +$167K | ﹤0.01% | 2878 |
|
|
2020
Q2 | $369K | Buy |
+25,923
| New | +$369K | ﹤0.01% | 2954 |
|